Chronic pain is one of the most prevalent, costly, and disabling health conditions in the United States. Estimates show that more than 11 percent of the American population suffer from chronic pain, yet the federal pain research investment has been minimal. In parallel with a gradual increased recognition of the problems of treating chronic pain, the opioid epidemic has emerged as a growing public health emergency. The intersection of these two crises lies in the fact that an unintended consequence of treating pain has been an increasing number of opioid prescriptions and diversion of drugs for illicit purposes. In May 2017, the National Institutes of Health (NIH), and the National Institute on Drug Abuse announced a publicprivate partnership to develop solutions to the opioid crisis and cut in half the time it takes to develop non-addictive analgesics. To advance the planning of NIH’s anticipated publicprivate partnerships, the National Academies‘ Forum on Neuroscience and Nervous Systems Disorders hosted a public workshop that brought together a diverse group of stakeholders from academia, federal agencies, advocacy organizations and companies developing therapeutics for pain and opioid use disorders. Participants discussed potential strategies to accelerate development of non-addictive pain medications and treatments for opioid use disorders. This publication summarizes the presentations and discussions from the workshop.
Board on Health Sciences Policy & Forum on Neuroscience and Nervous System Disorders
Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships [EPUB ebook]
Proceedings of a Workshop
Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships [EPUB ebook]
Proceedings of a Workshop
Dieses Ebook kaufen – und ein weitere GRATIS erhalten!
Sprache Englisch ● Format EPUB ● Seiten 106 ● ISBN 9780309474023 ● Herausgeber Clare Stroud & Lisa Bain ● Verlag National Academies Press ● Erscheinungsjahr 2018 ● herunterladbar 3 mal ● Währung EUR ● ID 7145572 ● Kopierschutz Adobe DRM
erfordert DRM-fähige Lesetechnologie